$HEAR
Turtle Beach Corp

2023 Q2 Form 10-Q Financial Statement

#000095017023017960 Filed on May 04, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $47.98M $51.44M $46.66M
YoY Change 16.18% 10.25% -49.85%
Cost Of Revenue $36.11M $37.31M $32.63M
YoY Change 8.06% 14.32% -43.93%
Gross Profit $11.87M $14.14M $14.03M
YoY Change 50.62% 0.78% -59.75%
Gross Profit Margin 24.74% 27.48% 30.07%
Selling, General & Admin $23.48M $16.53M $17.06M
YoY Change -2.67% -3.13% -8.17%
% of Gross Profit 197.74% 116.91% 121.63%
Research & Development $4.189M $4.101M $5.252M
YoY Change -18.44% -21.92% 31.53%
% of Gross Profit 35.28% 29.0% 37.44%
Depreciation & Amortization $1.219M $978.0K $1.504M
YoY Change -22.7% -34.97% 103.52%
% of Gross Profit 10.27% 6.92% 10.72%
Operating Expenses $27.67M $20.63M $22.32M
YoY Change -5.43% -7.55% -1.15%
Operating Profit -$15.79M -$6.492M -$8.287M
YoY Change -26.11% -21.66% -167.48%
Interest Expense $17.00K $163.0K -$109.0K
YoY Change -79.76% -249.54% -212.37%
% of Operating Profit
Other Income/Expense, Net -$198.0K -$120.0K -$719.0K
YoY Change -82.15% -83.31% 24.18%
Pretax Income -$15.97M -$6.775M -$9.115M
YoY Change -29.21% -25.67% -178.55%
Income Tax -$54.00K -$100.0K -$2.600M
% Of Pretax Income
Net Earnings -$15.92M -$6.705M -$6.476M
YoY Change -10.69% 3.54% -173.27%
Net Earnings / Revenue -33.18% -13.03% -13.88%
Basic Earnings Per Share -$0.93 -$0.40 -$0.40
Diluted Earnings Per Share -$0.93 -$0.40 -$0.40
COMMON SHARES
Basic Shares Outstanding 17.04M 16.58M 16.19M
Diluted Shares Outstanding 17.16M 16.58M 16.19M

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $15.79M $20.57M $23.70M
YoY Change 45.14% -13.19% -62.38%
Cash & Equivalents $15.79M $20.57M $23.70M
Short-Term Investments
Other Short-Term Assets $8.927M $9.108M $15.77M
YoY Change -34.39% -42.26% 7.3%
Inventory $67.83M $65.21M $117.4M
Prepaid Expenses
Receivables $20.25M $23.96M $11.81M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $112.8M $118.9M $168.7M
YoY Change -26.62% -29.55% -0.26%
LONG-TERM ASSETS
Property, Plant & Equipment $13.21M $6.144M $6.293M
YoY Change 114.93% -2.37% -11.23%
Goodwill $10.69M $10.69M
YoY Change 0.0%
Intangibles $2.238M $2.471M $5.464M
YoY Change -56.34% -54.78% -19.17%
Long-Term Investments
YoY Change
Other Assets $610.0K $589.0K $8.798M
YoY Change -95.53% -93.31% -1.15%
Total Long-Term Assets $26.74M $27.66M $39.34M
YoY Change -38.14% -29.69% 2.85%
TOTAL ASSETS
Total Short-Term Assets $112.8M $118.9M $168.7M
Total Long-Term Assets $26.74M $27.66M $39.34M
Total Assets $139.5M $146.5M $208.1M
YoY Change -29.15% -29.58% 0.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $34.04M $21.89M $32.90M
YoY Change 9.69% -33.47% 18.51%
Accrued Expenses $18.92M $27.19M $27.39M
YoY Change -2.76% -0.73% -21.53%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $55.84M $51.91M $60.28M
YoY Change -15.63% -13.89% -16.01%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $7.443M $7.703M $7.630M
YoY Change 1.49% 0.96% 50.23%
Total Long-Term Liabilities $7.443M $7.703M $7.630M
YoY Change 1.49% 0.96% 50.23%
TOTAL LIABILITIES
Total Short-Term Liabilities $55.84M $51.91M $60.28M
Total Long-Term Liabilities $7.443M $7.703M $7.630M
Total Liabilities $65.48M $61.75M $71.69M
YoY Change -15.29% -13.87% -10.71%
SHAREHOLDERS EQUITY
Retained Earnings -$139.2M -$123.3M
YoY Change 71.13%
Common Stock $17.00K $17.00K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $74.06M $84.76M $136.4M
YoY Change
Total Liabilities & Shareholders Equity $139.5M $146.5M $208.1M
YoY Change -29.15% -29.58% 0.31%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$15.92M -$6.705M -$6.476M
YoY Change -10.69% 3.54% -173.27%
Depreciation, Depletion And Amortization $1.219M $978.0K $1.504M
YoY Change -22.7% -34.97% 103.52%
Cash From Operating Activities -$4.779M $28.99M -$13.35M
YoY Change -82.87% -317.18% -163.3%
INVESTING ACTIVITIES
Capital Expenditures $365.0K $887.0K -$611.0K
YoY Change -161.24% -245.17% -126.8%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$365.0K -$887.0K -$611.0K
YoY Change -38.76% 45.17% -87.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 259.0K -19.01M 361.0K
YoY Change -98.37% -5365.37% -48.13%
NET CHANGE
Cash From Operating Activities -4.779M 28.99M -13.35M
Cash From Investing Activities -365.0K -887.0K -611.0K
Cash From Financing Activities 259.0K -19.01M 361.0K
Net Change In Cash -4.885M 9.177M -14.02M
YoY Change -61.26% -165.46% -186.1%
FREE CASH FLOW
Cash From Operating Activities -$4.779M $28.99M -$13.35M
Capital Expenditures $365.0K $887.0K -$611.0K
Free Cash Flow -$5.144M $28.10M -$12.74M
YoY Change -81.16% -320.63% -167.72%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
312000
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
42000
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001493761
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2023Q1 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherAssets
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-35465
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
TURTLE BEACH CORPORATION
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2767540
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
44 South Broadway
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
4th Floor
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
White Plains
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10601
CY2023Q1 dei City Area Code
CityAreaCode
888
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
496-8001
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17036026
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
51444000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
46662000
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
37305000
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
32633000
CY2023Q1 us-gaap Gross Profit
GrossProfit
14139000
CY2022Q1 us-gaap Gross Profit
GrossProfit
14029000
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9523000
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10829000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-6705000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4101000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5252000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7007000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6235000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
20631000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
22316000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-6492000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-8287000
CY2023Q1 us-gaap Interest Expense
InterestExpense
163000
CY2022Q1 us-gaap Interest Expense
InterestExpense
109000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-120000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-719000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6775000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9115000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-70000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2639000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-6705000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-6476000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.40
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.40
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.40
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.40
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16578000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16194000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16578000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16194000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-6705000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-6476000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
445000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-429000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
445000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-429000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6260000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6905000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20573000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11396000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
23955000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
43336000
CY2023Q1 us-gaap Inventory Net
InventoryNet
65214000
CY2022Q4 us-gaap Inventory Net
InventoryNet
71252000
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9108000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9196000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
118850000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
135180000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6144000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6362000
CY2023Q1 us-gaap Goodwill
Goodwill
10686000
CY2022Q4 us-gaap Goodwill
Goodwill
10686000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2471000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2612000
CY2023Q1 us-gaap Other Assets
OtherAssets
8361000
CY2022Q4 us-gaap Other Assets
OtherAssets
8547000
CY2023Q1 us-gaap Assets
Assets
146512000
CY2022Q4 us-gaap Assets
Assets
163387000
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
19053000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
21887000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
19846000
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
30023000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
25433000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
51910000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
64332000
CY2023Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
2135000
CY2022Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
2076000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7703000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8038000
CY2023Q1 us-gaap Liabilities
Liabilities
61748000
CY2022Q4 us-gaap Liabilities
Liabilities
74446000
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16604099
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16604099
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16569173
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16569173
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
17000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
17000
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
208999000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
206916000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-123303000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-116598000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-949000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1394000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
84764000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
88941000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
146512000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
163387000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-6705000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-6476000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
978000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1192000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
264000
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
47000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1959000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1537000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-89000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2329000
CY2023Q1 hear Revenue From Contract With Customer Sales Returns Reserve For Sales Returns
RevenueFromContractWithCustomerSalesReturnsReserveForSalesReturns
1178000
CY2022Q1 hear Revenue From Contract With Customer Sales Returns Reserve For Sales Returns
RevenueFromContractWithCustomerSalesReturnsReserveForSalesReturns
3285000
CY2023Q1 us-gaap Inventory Write Down
InventoryWriteDown
-561000
CY2022Q1 us-gaap Inventory Write Down
InventoryWriteDown
-874000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-20578000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-27423000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-7111000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
14615000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2162000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-7494000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-473000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1734000
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-271000
CY2022Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-657000
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
4226000
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-9863000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
28989000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13348000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
887000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
611000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-887000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-611000
CY2023Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
53892000
CY2023Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
72945000
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
125000
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
361000
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
80000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-19008000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
361000
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
83000
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-422000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
9177000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-14020000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11396000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37720000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20573000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23700000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
190000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
64000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
126000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
88941000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
445000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
124000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1959000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
84764000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
141369000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-6476000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-429000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
361000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1537000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
136362000
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of estimates</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">: The preparation of accompanying unaudited consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions about future events. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited consolidated financial statements and reported amounts of revenues and expenses during the reporting period. These estimates may change, as new events occur and additional information is obtained, and will be recognized in the consolidated financial statements in the period in which such changes occur. Future actual results could differ materially from these estimates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
CY2023Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
64360000
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
70407000
CY2023Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
854000
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
845000
CY2023Q1 us-gaap Inventory Net
InventoryNet
65214000
CY2022Q4 us-gaap Inventory Net
InventoryNet
71252000
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
34538000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
33812000
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
28394000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
27450000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6144000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6362000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-6705000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-6476000
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5140000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4171000
CY2023Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
2838000
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
4159000
CY2023Q1 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
2665000
CY2022Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
4147000
CY2023Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
1621000
CY2022Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
2527000
CY2023Q1 hear Accrued Freight Current
AccruedFreightCurrent
1279000
CY2022Q4 hear Accrued Freight Current
AccruedFreightCurrent
1746000
CY2023Q1 hear Accrued Expenses Current
AccruedExpensesCurrent
16480000
CY2022Q4 hear Accrued Expenses Current
AccruedExpensesCurrent
8683000
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
30023000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
25433000
CY2023Q1 hear Finite Lived Intangible Assets Foreign Currency Gross
FiniteLivedIntangibleAssetsForeignCurrencyGross
1466000
CY2023Q1 hear Finite Lived Intangible Assets Foreign Currency Accumulated Amortization
FiniteLivedIntangibleAssetsForeignCurrencyAccumulatedAmortization
1566000
CY2023Q1 hear Finite Lived Intangible Assets Foreign Currency Net
FiniteLivedIntangibleAssetsForeignCurrencyNet
100000
CY2023Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
11569000
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9098000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2471000
CY2022Q4 hear Finite Lived Intangible Assets Foreign Currency Gross
FiniteLivedIntangibleAssetsForeignCurrencyGross
1375000
CY2022Q4 hear Finite Lived Intangible Assets Foreign Currency Accumulated Amortization
FiniteLivedIntangibleAssetsForeignCurrencyAccumulatedAmortization
1344000
CY2022Q4 hear Finite Lived Intangible Assets Foreign Currency Net
FiniteLivedIntangibleAssetsForeignCurrencyNet
31000
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
11660000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9048000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2612000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
773000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1003000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
425000
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
170000
CY2023Q1 hear Finite Lived Intangible Assets Amortization Expense After Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree
0
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2371000
CY2023Q1 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
200000
CY2022Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
100000
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
42000
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
47000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-70000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2639000
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.010
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.290
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-100000
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.010
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2600000
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.290
CY2023Q1 hear Unrecognized Tax Benefits Inclusive Of Interest And Penalties
UnrecognizedTaxBenefitsInclusiveOfInterestAndPenalties
2900000
CY2023Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
800000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1959000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1537000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
550000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
6000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
543000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1577545
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.66
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y9M21D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2465015
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
21141
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.90
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
5843
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
14.98
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1550561
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.66
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y7M6D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5405871
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1547737
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
7.73
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y7M2D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
5395849
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1333462
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.65
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y4M9D
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
4833381
CY2023Q1 hear Sharebased Compensation Arrangement By Sharebased Payment Award Forfeiture Period After Ending Employment
SharebasedCompensationArrangementBySharebasedPaymentAwardForfeiturePeriodAfterEndingEmployment
P90D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
100000
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
300000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16578000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16194000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16578000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16194000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.40
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.40
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.40
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.40
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2970000
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3068000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
51444000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
46662000
CY2020Q2 hear Number Of Shareholders
NumberOfShareholders
8
CY2020Q3 hear Number Of Motions
NumberOfMotions
2
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
618000
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
856000
CY2023Q1 us-gaap Product Warranty Expense
ProductWarrantyExpense
185000
CY2022Q1 us-gaap Product Warranty Expense
ProductWarrantyExpense
121000
CY2023Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
187000
CY2022Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
188000
CY2023Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
616000
CY2022Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
789000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7772000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1085000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7288000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
8373000
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y7M6D
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
400000
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
300000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
968000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1437000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1451000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1361000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1383000
CY2023Q1 hear Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
3182000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
9782000
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1409000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
8373000

Files In Submission

Name View Source Status
hear-20230331_cal.xml Edgar Link unprocessable
hear-20230331_def.xml Edgar Link unprocessable
0000950170-23-017960-index-headers.html Edgar Link pending
0000950170-23-017960-index.html Edgar Link pending
0000950170-23-017960.txt Edgar Link pending
0000950170-23-017960-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hear-20230331.htm Edgar Link pending
hear-20230331.xsd Edgar Link pending
hear-ex31_1.htm Edgar Link pending
hear-ex31_2.htm Edgar Link pending
hear-ex32_1.htm Edgar Link pending
img252835359_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
hear-20230331_lab.xml Edgar Link unprocessable
hear-20230331_pre.xml Edgar Link unprocessable
hear-20230331_htm.xml Edgar Link completed
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending